MESO-CAR T cells

CAR T cell therapy targeting mesothelin · Second Affiliated Hospital, School of Medicine, Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MESO-CAR T cells, covering 2019-04-16 to 2019-04-16. Get the full timeline:

Most recent: Clinical Trial Update: MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer [Phase 1, Phase 2]